COVID-19 In Silico Drug with Zingiber officinale Natural Product Compound Library Targeting the Mpro Protein RM Wijaya, MA Hafidzhah, VD Kharisma, ANM Ansori, AA Parikesit Makara Journal of Science 25 (3), 5, 2021 | 87* | 2021 |
Severe Acute Respiratory Syndrome Coronavirus-2 Emergence and Its Treatment with Alternative Medicines: A Review ANM Ansori, VD Kharisma, A Fadholly, MR Tacharina, Y Antonius, ... Research Journal of Pharmacy and Technology 14 (10), 5551-5557, 2021 | 74 | 2021 |
Genetic Variant of SARS-CoV-2 Isolates in Indonesia: Spike Glycoprotein Gene ANM Ansori, VD Kharishma, SS Muttaqin, Y Antonius, AA Parikesit Journal of Pure and Applied Microbiology 14 (Suppl1), 2020 | 73 | 2020 |
Bioactive Compounds from Mangosteen (Garcinia mangostana L.) as an Antiviral Agent via Dual Inhibitor Mechanism against SARSCoV-2: An In Silico Approach ANM Ansori, VD Kharisma, AA Parikesit, FA Dian, RT Probojati, ... Pharmacognosy Journal 14 (1), 2022 | 68 | 2022 |
Immunoinformatics approach in designing epitope-based vaccine against meningitis-inducing bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae … H Zahroh, A Ma'rup, USF Tambunan, AA Parikesit Drug target insights 10, DTI. S38458, 2016 | 51 | 2016 |
Utilization of Secondary Metabolites in Algae Kappaphycus alvarezii as a Breast Cancer Drug with a Computational Method AF Dibha, S Wahyuningsih, ANM Ansori, VD Kharisma, MH Widyananda, ... Pharmacognosy Journal 14 (3), 2022 | 48 | 2022 |
In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC) USF Tambunan, N Bramantya, AA Parikesit BMC bioinformatics 12 (13), S23, 2011 | 44 | 2011 |
Screening of commercial cyclic peptide as inhibitor NS5 methyltransferase of Dengue virus through Molecular Docking and Molecular Dynamics Simulation USF Tambunan, H Zahroh, BB Utomo, AA Parikesit Bioinformation 10 (1), 23, 2014 | 32 | 2014 |
Biological Activity of Kencur (Kaempferia Galanga L.) against SARS-CoV-2 Main Protease: In Silico Study AF Dibha, S Wahyuningsih, VD Kharisma, ANM Ansori, MH Widyananda, ... International journal of health sciences 6 (S1), 468-480, 2022 | 29 | 2022 |
Computational design of disulfide cyclic peptide as potential inhibitor of complex NS2B-NS3 dengue virus protease USF Tambunan, N Apriyanti, AA Parikesit, W Chua, K Wuryani African Journal of Biotechnology 10 (57), 12281-12290, 2011 | 29 | 2011 |
Screening of commercial cyclic peptides as inhibitor envelope protein dengue virus (DENV) through molecular docking and molecular dynamics AA Parikesit, USF Tambunan Pakistan Journal of Biological Sciences 16 (24), 1836, 2013 | 27 | 2013 |
In silico analysis of envelope Dengue Virus-2 and envelope Dengue Virus-3 protein as the backbone of Dengue Virus tetravalent vaccine by using homology modeling method US Friend, AA Parikesit, RI Taufik, F Amelia OnLine Journal of Biological Sciences 9 (1), 6-16, 2009 | 26 | 2009 |
Molecular simulation of compounds from n-hexane fraction of Sonchus arvensis L. leaves as SARS-CoV-2 antiviral through inhibitor activity targeting strategic viral protein DK Wahyuni, S Wacharasindhu, W Bankeeree, H Punnapayak, ... Journal of Pharmacy & Pharmacognosy Research 10 (6), 1126-1138, 2022 | 25 | 2022 |
Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis USF Tambunan, AH Alkaff, MAF Nasution, AA Parikesit, D Kerami Journal of Molecular Graphics and Modelling 74, 366-378, 2017 | 25 | 2017 |
Screening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2. US Tambunan, H Zahroh, AA Parikesit, S Idrus, D Kerami Drug target insights 9, 33-49, 2014 | 25 | 2014 |
Modification of-Adenosyl--Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation USF Tambunan, MAF Nasution, F Azhima, AA Parikesit, EP Toepak, ... Drug Target Insights 2017 (11), 0-0, 2017 | 24 | 2017 |
Natural products repurposing of the H5N1-based lead compounds for the most fit inhibitors against 3C-like protease of SARS-CoV-2 AA Parikesit, R Nurdiansyah Journal of Pharmacy & Pharmacognosy Research 9 (5), 730-745, 2021 | 22 | 2021 |
In silico design of cyclic peptides as influenza virus, a subtype H1N1 neuraminidase inhibitor USF Tambunan, N Amri, AA Parikesit African Journal of Biotechnology 11 (52), 11474-11491, 2012 | 22 | 2012 |
The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia Y Maladan, H Krismawati, T Wahyuni, R Tanjung, K Awaludin, KA Audah, ... BMC genomics 22 (1), 1-11, 2021 | 19 | 2021 |
Vaccine design for H5N1 based on B-and T-cell epitope predictions USF Tambunan, FRP Sipahutar, AA Parikesit, D Kerami Bioinformatics and Biology insights 10, BBI. S38378, 2016 | 18 | 2016 |